These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28087649)

  • 1. Identification of unique essential proteins from a Mycobacterium tuberculosis F15/LAM4/KZN phage secretome library.
    Chiliza TE; Pillay M; Pillay B
    Pathog Dis; 2017 Jan; 75(1):. PubMed ID: 28087649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients' sera identifies unique active- and latent-TB specific biomarkers.
    Chiliza TE; Pillay M; Naidoo K; Pillay B
    Tuberculosis (Edinb); 2019 Mar; 115():161-170. PubMed ID: 30948172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.
    Pillay M; Sturm AW
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):223-30. PubMed ID: 20074415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
    Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
    Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
    Naidoo CC; Pillay M
    J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells.
    Mvubu NE; Pillay B; McKinnon LR; Pillay M
    Cytokine; 2018 Apr; 104():53-64. PubMed ID: 29032986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
    Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
    Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtractive screening with the Mycobacterium tuberculosis surface protein phage display library.
    Liu S; Han W; Sun C; Lei L; Feng X; Yan S; Diao Y; Gao Y; Zhao H; Liu Q; Yao C; Li M
    Tuberculosis (Edinb); 2011 Nov; 91(6):579-86. PubMed ID: 21900047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics tools and databases for whole genome sequence analysis of Mycobacterium tuberculosis.
    Faksri K; Tan JH; Chaiprasert A; Teo YY; Ong RT
    Infect Genet Evol; 2016 Nov; 45():359-368. PubMed ID: 27637931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion to and invasion of pulmonary epithelial cells by the F15/LAM4/KZN and Beijing strains of Mycobacterium tuberculosis.
    Ashiru OT; Pillay M; Sturm AW
    J Med Microbiol; 2010 May; 59(Pt 5):528-533. PubMed ID: 20110390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic characterization of Mycobacterium tuberculosis reveals potential targets of bostrycin.
    Yuan P; He L; Chen D; Sun Y; Ge Z; Shen D; Lu Y
    J Proteomics; 2020 Feb; 212():103576. PubMed ID: 31706025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis.
    Dookie N; Sturm AW; Moodley P
    Infect Drug Resist; 2014; 7():223-8. PubMed ID: 25187730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
    Rachman H; Kaufmann SH
    Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Kumar S; Sahu P; Jena L
    Int J Mycobacteriol; 2019; 8(3):252-261. PubMed ID: 31512601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity.
    Deng J; Bi L; Zhou L; Guo SJ; Fleming J; Jiang HW; Zhou Y; Gu J; Zhong Q; Wang ZX; Liu Z; Deng RP; Gao J; Chen T; Li W; Wang JF; Wang X; Li H; Ge F; Zhu G; Zhang HN; Gu J; Wu FL; Zhang Z; Wang D; Hang H; Li Y; Cheng L; He X; Tao SC; Zhang XE
    Cell Rep; 2014 Dec; 9(6):2317-29. PubMed ID: 25497094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.